Headshot of Kathleen Boozang

Kathleen Boozang

Visiting Professor of Law


Professor Boozang joined Seton Hall Law in 1990 as the founder of the Law School’s top-ranked Center for Health & Pharmaceutical Law. She has served in multiple administrative capacities at Seton Hall University including law school dean, associate dean, associate dean for academic advancement, and Vice Provost. She also established Seton Hall Law’s graduate degreesDivision of Online Learning and global life sciences compliance training programs.   Professor Boozang received her BS from Boston College, her JD from Washington University in St. Louis where she was inducted into the Order of the Coif and served as the managing editor of Law Quarterly (now the Law Review), and her LL.M. from Yale.  She practiced health law for several years with a St. Louis law firm, primarily representing a multi-state healthcare system.  In Spring 2023 Professor Boozang was a Visiting Scholar at the Petrie-Flom Center for Health Law Policy, Biotechnology and Bioethics and Harvard Law School.  She is thrilled to be visiting UCSF for the Fall 2023 semester teaching health law courses.

Professor Boozang has taught a variety of health law courses throughout her career in person and online including health law, health care fraud and corruption, tax-exempt organizations, Complementary and Alternative Medicine, corporate compliance, and death and dying. She has also taught Torts and Contracts.

Professor Boozang’s scholarship has evolved throughout her career.  Her research includes articles on bioethical issues, nonprofit governance, legal implications of providing and paying for complementary and alternative medicine, and the law related to fraud, corporate compliance and conflicts of interest.   She is currently working on two articles addressing the impact of NIL compensation and collectives on the dynamics of medical treatment decision-making for intercollegiate athletes.  Professor Boozang is also very interested in the intersection of corporate ethics and compliance and ESG in the life sciences industry.

Professor Boozang is a Fellow of The Hastings Center, an independent nonprofit bioethics research institute, as well as a Fellow of the American Bar Foundation, an honorary organization of legal practitioners. She is also a member of the American Law Institute and participated on the consultant groups for the Principles of Nonprofit Law and Corporate Compliance. She has served on the Editorial Board of the Journal of Health and Life Sciences Law and is a past editor-in-chief of the Journal of Law, Medicine & Ethics. She is past president of the American Society of Law, Medicine & Ethics (ASLME) and also previously sat on the Advisory Board of the Journal of Health Law. Professor Boozang served for many years on the Board of Directors of the American Health Law Association (AHLA) which elected her to be a fellow.

Professor Boozang is a frequent member of ABA law school site accreditation teams.

Professor Boozang has served on multiple boards, including Sacred Heart University in Connecticut, the Board of Trustees of the St. Joseph Healthcare System in New Jersey, ASLME, AHLA, and the Cathedral Health System.

In 2013, the ASLME conferred upon Professor Boozang the Jay Healy Health Law Teacher Award.


The Role and Place of Compliance within Life Sciences: The Imperative of Chief Ethics and Compliance Officer Independence, (2018) (with Timothy Glynn)

The Ban on Off-Label Promotion and the False Claims Act: Analyzing a Decentralized, Public-Private Enforcement Regime, (2015) (collaborator)

Symposium Introduction: Is a For-Profit Structure a Viable Alternative for a Health Care Ministry?  (2013)

 Responsible Corporate Officer Doctrine: When is Falling Down on the Job a Crime?, 6 J. Health L & Pol’y 77 (2012)

The New Relator: In-House Counsel and Compliance Officers, 6 J. Health & Life Sciences L. 16 (2012)

Toward Evidence-Based Conflicts of Interest Training for Physician-Investigators, J L Med Ethics (2012) (with Carl Coleman and Kate Greenwood)

 Transparency: It May Not Be Sufficient, 4 Life Science Compliance 14 (2012)

 An Argument Against Embedding Conflicts of Interest Disclosures in Informed Consent, 4 J.H. & Life Sciences L. 230 (2011) (with Carl H. Coleman and Kate Greenwood)

The Limits of Disclosure as a Response to Financial Conflicts of Interest in Clinical Research, A White Paper by The Center for Health & Pharmaceutical Law & Policy (2010) (collaborator)

A New Pathway to Market for Biosimilars, 4 J. H & Life Sciences L. 121 (2010) (with Judith Toffentti)

“Monitoring” Corporate Corruption: DOJ’s Use of Deferred Prosecution Agreements in Health Care, 35 Am. J.L. Med. 89 (Spring 2009) (with Simone Handler-Hutchinson)

Conflicts of Interest in Clinical Trial Recruitment & Enrollment: A Call for Increased Oversight, A White Paper by The Center for Health & Pharmaceutical Law & Policy (2009) (collaborator)

Board Independence and Transparency: Searching for the Key to Good Governance, 1 J. Health & Life Sci. L. 127 (2009)

Drug and Device Promotion: Charting A Course for Policy Reform, A White Paper by The Center for Health & Pharmaceutical Law & Policy (2009) (collaborator)

A Civil Law Analysis: The Place of Religion in Treatment Termination Decision-Making, 15 Temp. Civ. Rts. L. Rev. 345 (2007)

Does Director Independence Improve Nonprofit Governance?, 75 Tenn. L. Rev. 83 (2007)

Mission, Margin and Trust in the Nonprofit Healthcare Enterprise, 5 Yale J. Health Pol’y, L. and Ethics 1 (2005) (T.L. Greaney)

Legal and Ethical Issues in Complementary and Alternative Medicine, in Complementary and Alternative Medicine: An Evidence Based Approach, Spencer & Jacobs (John Spencer & Joe Jacobs) (2003)

Therapeutic Placebos: Making the Case for Patient Deception, 54 Fla. L. Rev. 687 (2002)

Is the Alternative Medicine? Managed Care Apparently Thinks So, 32 Conn. L. Rev. 567 (2000)

National Policy on CAM: The White House Commission Report, 31 J.L. Med. & Ethics 251 (2003)

Western Medicine Opens the Door to Alternative Medicine, XXIV J. Law & Med. 185 (1998)

Developing a Public Policy Toward the Sectarian Provider: Accommodating Religious Beliefs and Obtaining Patient Access to Care, 24 J. Law, Medicine & Ethics 89 (1996)

The Survival of Religious Hospitals in a World of Reformed Health Care, 31 Houston L. Rev. 1429 (1995)



  • Healthcare Providers and the Law
  • Health Law and Policy Seminar
  • Writing Requirement for Lawyers